Price
CHART BY
Historical dividends and forecast
AstraZeneca ADR Representing 0.5 has so far distributed 2.17 in 2026. The next dividend will be paid on 08.09.2026
1.567
CHART BY
Frequently asked questions
What is the Earnings Per Share (EPS) for AstraZeneca ADR Representing 0.5?
AstraZeneca ADR Representing 0.5's Earnings Per Share (EPS) over the trailing twelve months (TTM) is 3.353. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for AstraZeneca ADR Representing 0.5's stock?
Currently, 30 analysts cover AstraZeneca ADR Representing 0.5's stock, with a consensus target price of $107.66. Analyst ratings provide insights into the stock's expected performance.
What is AstraZeneca ADR Representing 0.5's revenue over the trailing twelve months?
Over the trailing twelve months, AstraZeneca ADR Representing 0.5 reported a revenue of $60.48B.
Is AstraZeneca ADR Representing 0.5 paying dividends?
Yes, AstraZeneca ADR Representing 0.5 is paying dividends. The next payment is scheduled for 08.09.2026, with an expected amount of .
What is the EBITDA for AstraZeneca ADR Representing 0.5?
AstraZeneca ADR Representing 0.5's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $19.87B. EBITDA measures the company's overall financial performance.
What is the free cash flow of AstraZeneca ADR Representing 0.5?
AstraZeneca ADR Representing 0.5 has a free cash flow of $11.60B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does AstraZeneca ADR Representing 0.5 have, and what sector and industry does it belong to?
AstraZeneca ADR Representing 0.5 employs approximately 96,100 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
Financials
- EPS (TTM)
- 3.353
- Revenue (TTM)
- $60.48B
- EBITDA (TTM)
- $19.87B
- Free Cashflow (TTM)
- $11.60B
Analyst Ratings
The price target is $107.66 and the stock is covered by 30 analysts.
Buy
24
Hold
4
Sell
2
Information
AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.
- Employees
- 96,100
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- Primary Ticker
- AZN
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet